Table 2 |
|||
|
Relationship between immunohistochemical features and breast carcinomas expressing CD44+CD24-/low immunophenotype and carcinomas that do not express this immunophenotype |
|||
|
Feature |
CD44+CD24-/low positive |
CD44+CD24-/low negative |
p-value |
|
|
|||
|
RE |
0.340 |
||
|
|
|||
|
Pos |
53 |
108 |
|
|
|
|||
|
Neg |
36 |
56 |
|
|
|
|||
|
|
|||
|
RP |
0.141 |
||
|
|
|||
|
Pos |
47 |
103 |
|
|
|
|||
|
Neg |
42 |
61 |
|
|
|
|||
|
|
|||
|
p53 |
0.786 |
||
|
|
|||
|
Pos |
56 |
106 |
|
|
|
|||
|
Neg |
33 |
58 |
|
|
|
|||
|
|
|||
|
HER-2 |
0.013* |
||
|
|
|||
|
Pos |
10 |
40 |
|
|
|
|||
|
Neg |
79 |
124 |
|
|
|
|||
|
|
|||
|
Ki67 |
0.410 |
||
|
|
|||
|
Pos |
34 |
54 |
|
|
|
|||
|
Neg |
55 |
110 |
|
|
|
|||
|
|
|||
|
HIF-1a |
0.039* |
||
|
|
|||
|
Pos |
26 |
29 |
|
|
|
|||
|
Neg |
63 |
135 |
|
|
|
|||
|
|
|||
|
CAIX |
0.551 |
||
|
|
|||
|
Pos |
26 |
41 |
|
|
|
|||
|
Neg |
63 |
123 |
|
|
|
|||
|
*Statistically significant. |
|||
|
Oliveira-Costa et al. Diagnostic Pathology 2011 6:73 doi:10.1186/1746-1596-6-73 |
|||
